DOCSLIB.ORG

The Ins and Outs of Detection and Treatment

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Ins and Outs of Detection and Treatment Canine Cushing’s Case Files: THE INS AND OUTS OF DETECTION AND TREATMENT SPONSORED BY DECHRA VETERINARY PRODUCTS Canine Cushing’s Case Files: THE INS AND OUTS OF DETECTION AND TREATMENT CLINICAL ARTICLES PRACTICE-RELATED ARTICLES 6 DALI 26 Your veterinary team’s role in identifying by Audrey K. Cook, BVM&S, MRCVS, DACVIM dogs with hyperadrenocorticism 8 PRINCESS 28 Your veterinary team’s role in by Lori Thompson, DVM, DACVD treating and monitoring dogs with hyperadrenocorticism 10 MITCH by David Bruyette, DVM, DACVIM 30 The economics of managing hyperadrenocorticism in dogs 12 HOLLY by Fritz Wood, CPA, CFP by Christopher G. Byers, DVM, DACVECC, DACVIM 32 Avoiding practitioner pitfalls 14 LIBBY with canine Cushing’s cases by Todd M. Archer, DVM, MS, DACVIM by Andy Roark, DVM, MS 16 BOCA by Cynthia Nichols, DVM DECHRA VETERINARY PRODUCTS 18 HOWIE SUPPLEMENTAL RESOURCES by Christopher G. Byers, DVM, DACVECC, DACVIM 34 Diagnosis, Treatment and Monitoring 20 CALLIE of Hyperadrenocorticism by Orla Mahony, MVB, DACVIM, DECVIM 37 Technical Brochure for VETORYL® 22 Dogs with recurring pyoderma Capsules (trilostane) by Thomas Lewis, DVM, DACVD 24 5 questions veterinarians ask the Dechra Veterinary Products Technical Services Team hen you know the ins and outs of something, it Dechra Veterinary Products, the manufacturer of VETORYL® W Capsules (trilostane), understands how challenging the diag- peculiarities, or technicalities of a certain subject. The nosis and management of canine hyperadrenocorticism, or phrase the ins and outs also has a second meaning — the Cushing’s syndrome, can be. The disease can manifest in many windings of a road or path. When faced with a case of hyperadrenocorticism in a dog, you may feel you are on a best treatment for these patients, Dechra Veterinary Products winding path. Often the diagnosis is not straightforward sponsored a 12-article series for your reference, Canine Cush- or obvious. The clinical signs can be subtle or have a ing’s Case Files: The Ins and Outs of Detection and Treatment, that was inserted in dvm360 magazine throughout 2013. That series gradual onset. And because hyperadrenocorticism is the core of this e-book, along with two bonus case reports, available only here. changes they’re observing to “normal aging.” The veterinarians who managed the eight clinical cases in 2 | CANINE CUSHING’S CASE FILES H pituitary-dependent (80% to 85% of spontaneous cases) or adrenal- dependent (15% to 20% of cases), the clinical and laboratory abnormal- ities associated with it result from chronic hypercortisolemia. Clinical this e-book describe their diagnostic process and their treat- signs of hyperadrenocorticism at the time of diagnosis can vary widely, ment protocol and share their personal perspective on each and they develop so gradually that owners often mistake the signs for case. In addition, a veterinary dermatologist provides insight “normal” aging. Being aware of the more subtle signs of canine hyper- on why practitioners should consider hyperadrenocorticism in adrenocorticism can be key to early diagnosis and initiation of therapy. dogs that have recurring pyoderma. Whenever possible, pituitary-dependent hyperadrenocorticism As with any type of case, client communication, involvement of the entire veterinary practice team, and understanding the and patient monitoring. Early diagnosis and management of canine - hyperadrenocorticism may not only improve the patient’s clinical ing patients with chronic diseases such as Cushing’s syndrome. To signs but may also keep the more severe consequences of Cushing’s address such issues, this e-book also includes articles on: syndrome from developing. • A the Dechra Veterinary Products Technical Services Team Common clinical signs of canine hyperadrenocorticism about canine hyperadrenocorticism and VETORYL® Capsules (trilostane). Polyuria (owners may complain Alopecia T he veterinary practice team’s role in educating and com- • • • of housesoiling) • Recurrent skin disease municating with clients about identifying, treating, and • Polydipsia • Lethargy monitoring dogs with hyperadrenocorticism • P olyphagia (owners may • Pendulous abdomen • - complain of food stealing or • E xcessive panting ing’s patients on your practice’s bottom line excessive begging) • Thin skin • Ways to avoid common practitioner pitfalls when providing long-term healthcare for a patient with a chronic disease Other clinical signs may include hypertension, comedones, sebor- rhea, heat intolerance, hyperpigmentation, calcinosis cutis, bruising, At the back of this e-book, we have included additional algo- facial paralysis, failure to cycle, clitoral hypertrophy, testicular atrophy, poor hair regrowth after surgery, recurrent urinary tract infections, helpful — Diagnosis, Treatment, and Monitoring of Hyperadreno- pyoderma in an older dog. corticism (p. 34-36), and the full Technical Brochure for VETORYL® Capsules (trilostane) (p. 37-52). Beyond this e-book, we provide a number of Cushing’s-relat- ed online resources at www.dechra-us.com and Continuing Education modules in our Dechra Academy (click on the Dechra CE tab on the Dechra website). The Dechra Academy contains VETORYL® Capsules (trilostane) are the only FDA-approved drug multiple complimentary RACE-approved CE modules on indicated for the treatment of pituitary-dependent and adrenal- endocrine diseases presented by key opinion leaders. dependent hyperadrenocorticism (PDH and ADH) in dogs. Trilostane, Diagnostic and treatment algorithms, client brochures, patient the active ingredient, blocks hormone production in the adrenal cortex monitoring forms, case studies and more can be found on the Dechra US website. To order printed copies of any of the dogs with PDH and ADH resources contact Dechra Customer Support at (866) 683-0660. For case consultations please contact our highly skilled • T he use of VETORYL Capsules is contraindicated in dogs that have Veterinary Technical Support Team at (866) 933-2472. demonstrated hypersensitivity to trilostane. The main purpose of this e-book and all of our other • D o not use VETORYL Capsules in animals with primary hepatic resources is to let you know that we are here to help you be • successful when you are faced with canine Cushing’s patients. D o not use in pregnant dogs. Studies conducted with trilostane We want to help guide you along the sometimes winding path pregnancy loss. of diagnosing and managing dogs with hyperadrenocorticism • T he most common adverse reactions reported are poor/reduced and provide you with the information and tools you need to appetite, vomiting, lethargy/dullness, and weakness. • Occasionally, more serious reactions, including severe depression, canine Cushing’s syndrome. hemorrhagic diarrhea, collapse, hypoadrenocortical crisis or adrenal necrosis/rupture may occur, and may result in death. —Dechra Veterinary Products SPONSORED BY DECHRA VETERINARY PRODUCTS ©2018 | 3 Treat their Hyperadrenocorticism. Help restore their vitality. VETORYL® Capsules (trilostane) are the only FDA veterinary- approved treatment for pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs (Cushing’s syndrome). They contain the active ingredient trilostane, which blocks the excessive production of cortisol. Daily administration of VETORYL Capsules can greatly reduce the clinical signs associated with Cushing’s syndrome, helping to restore the dog’s vitality. Clinical studies demonstrated that treatment with VETORYL Capsules resulted in decreased thirst, decreased frequency of urination, decreased panting, and improvement of appetite and activity.1 Activity levels began to show improvement within 14 days of treatment. anorexia, lethargy/depression, vomiting, diarrhea, elevated liver enzymes, elevated potassium with or without elevated sodium, elevated has been reported as an outcome of these adverse events. VETORYL Capsules are not for use in dogs with primary hepatic or renal disease, or in pregnant dogs. Refer to the prescribing information for complete details or visit www.Dechra-US.com. 24 Hour Technical Support: 866-933-2472 | www.dechra-us.com | [email protected] VETORYL is a trademark of Dechra LTD. ©2018, Dechra Ltd. NADA 141-291, Approved by FDA CAUTION: Federal law restricts this drug to use by or on the order of licensed veterinarian. Dechra is a registered trademark of 1http://www.fda.gov/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm049823.htm Dechra Pharmaceuticals PLC. Canine Cushing’s Case Files: THE INS AND OUTS OF DETECTION AND TREATMENT CONTRIBUTING AUTHORS Todd M. Archer, David Bruyette, Christopher G. Byers, Audrey K. Cook, Thomas Lewis, DVM, MS, DACVIM DVM, DACVIM DVM, DACVECC, DACVIM BVM&S, MRCVS, DACVIM, DVM, DACVD DECVIM, DABVP Orla Mahony, Cynthia Nichols, DVM Andy Roark, DVM, MS Lori Thompson, Fritz Wood, CPA, CFP MVB, DACVIM, DECVIM DVM, DACVD © 2018 Dechra Veterinary Products http://www.dechra-us.comwww.dechra-us.com • www.dechra-us.com/CEhttp://www.dechra-us.com/CE Dechra Veterinary Products 7015 College Blvd., Suite 525 Overland Park, KS 66211 Veterinary Technical Support: (866) 933-2472 Customer Support: (866) 683-0660 SPONSORED BY DECHRA VETERINARY PRODUCTS ©2018 | 5 DALI 10-year-old, spayed female dachshund weighing 9 lb (4.1 kg) Presenting complaint and history Dali was referred to Texas A&M’s Veterinary Teaching Hospital for evaluation of a mammary mass that had progressively enlarged over a three-month period. Several years before refer- ral, Dali had two malignant mammary masses removed. Dali
Load more

Recommended publications
  • CARE PLAN Electrolyte and Fluid Imbalance
    CARE PLAN Electrolyte and Fluid Imbalance . Related to: Check all that apply Endocrine dysfunction Treatment/Drug side effects Urinary difficulties Nutritional deficiency Tissue trauma Renal dysfunction Post-op complications Trauma Other _____________ Status: Achieved/ Progressing/Not Date/Select Outcome Select Interventions Met (comment for negative variances) Serum electrolytes, Perform initial/routine BUN, blood gases will assessments, assess be within desired limits for neurological manifestations indicating electrolyte imbalance. Report findings to clinician (MD, PA, NP) promptly. Implement therapeutic actions (i.e., appropriate diet, administer replacement electrolytes—sodium bicarb, mag sulfate, etc., as ordered) Assess/monitor serum levels of electrolytes; report finding to MD promptly Monitor for associated complications Absence of cardiac Assess/monitor cardiac dysrhythmias rhythm Published by Cinahl Information Systems, a division of EBSCO Information Services. Copyright©2016, Cinahl Information Systems. All rights reserved. No part of this may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the publisher. Cinahl Information Systems accepts no liability for advice or information given herein or errors/omissions in the text. It is merely intended as a general informational overview of the subject for the healthcare professional. Cinahl Information Systems, 1509 Wilson Terrace,
    [Show full text]
  • Electrolyte Imbalance in Children with Severe Acute Malnutrition at a Tertiary Care Hospital in Pakistan: a Cross-Sectional Study
    Open Access Original Article DOI: 10.7759/cureus.10541 Electrolyte Imbalance in Children With Severe Acute Malnutrition at a Tertiary Care Hospital in Pakistan: A Cross-Sectional Study Mohammad Raza 1, 2 , Sohail Kumar 3 , Muzamil Ejaz 2 , Dua Azim 3 , Saad Azizullah 2 , Azhar Hussain 4, 5 1. Pediatrics, The Indus Hospital, Karachi, PAK 2. Pediatrics, Dow Medical College, Dr. Ruth K. M. Pfau Civil Hospital, Karachi, PAK 3. Internal Medicine, Dow Medical College, Dr. Ruth K. M. Pfau Civil Hospital, Karachi, PAK 4. Healthcare Administration, Franklin University, Columbus, USA 5. Medicine, Xavier University School of Medicine, Oranjestad, ABW Corresponding author: Mohammad Raza, [email protected] Abstract Background Malnutrition is a significant public health concern and a leading contributor to the global burden of children’s diseases, affecting 50 to 150 million children under the age of five years worldwide. Globally, undernutrition accounts for approximately 33% of the deaths among under-fives. South Asia alone contributes to 50% and 38.8% of the world’s population of wasted and stunted children, respectively. In Pakistan, malnutrition is the leading cause of childhood mortality, accounting for nearly 35% of all deaths under five years of age. Severe acute malnutrition (SAM), the most severe form of malnutrition, is often associated with electrolyte imbalances. This study aimed to determine the frequency of electrolyte imbalance in children with SAM admitted at a tertiary care hospital. Methods This cross-sectional study includes 184 patients with SAM aged between 6 and 60 months, who were admitted at the inpatient Department of Pediatrics, Dr. Ruth K.
    [Show full text]
  • Electrolyte Imb-Hypercalcemia
    HYPERCALCEMIA (Last updated 01/10/2020; Last reviewed 03/11/2017; Reviewers: Rudy Tedja, DO, Bibek Karki, MBBS) PRESENTING COMPLAINT: Weakness, fatigue, constipation, depression FINDINGS A Check airway B ↓/N RR C ↑/N BP, ↓HR D Variable altered (V,P,U,D)* E Profound muscle weakness, bone pain LPC ↑Ca, ↑/↓/N PTH, ↑/↓/N P UPC Renal stone *V (verbal), P (pain), U (unconsciousness), D (delirious) UPC (point of care ultrasound) LPC (point of care labs) OTHER HISTORY Signs and symptoms Neurological: Lethargy, confusion, stupor, coma Cardiac: Shortened QT interval, supraventricular, ventricular arrhythmias, bradycardia Renal: Polyuria, nephrolithiasis, nephrogenic diabetes insipidus, renal insufficiency, renal tubular acidosis MSK: Bone pain GI: Nausea/vomiting, abdominal pain, pancreatitis Predisposing Conditions: Elderly are predisposed to neuropsychiatric symptoms and known history of malignancy DIFFERENTIAL DIAGNOSIS Other causes of drug induced or metabolic encephalopathy/coma, delirium, intracranial pathology OTHER INVESTIGATIONS Lab: Creatinine Severity: Mild: Calcium < 12 mg/dL; moderate: Calcium 12-14 mg/dL; severe: Calcium >14 mg/dL Monitoring: Calcium level every 8 hours THERAPEUTIC INTERVENTIONS Initial therapy 1 o Stop any offending agents, such as thiazides, lithium, exogenous calcium, vitamin A supplementation, vitamin D supplementation o Intravascular volume repletion with isotonic saline at initial rate of 200-300 ml/hr . Depending on renal function and history of CHF . Titrate rate of normal saline to goal urine
    [Show full text]
  • Hypernatremia at Admission Predicts Poor Survival
    Seo et al. BMC Palliative Care (2020) 19:94 https://doi.org/10.1186/s12904-020-00607-z RESEARCH ARTICLE Open Access Hypernatremia at admission predicts poor survival in patients with terminal cancer: a retrospective cohort study Min-Seok Seo1,2, In Cheol Hwang3*† , Jaehun Jung4*†, Hwanhee Lee3, Jae Hee Choi3 and Jae-Yong Shim2 Abstract Background: Although palliative care providers, patients, and their families rely heavily on accurate prognostication, the prognostic value of electrolyte imbalance has received little attention. Methods: As a retrospective review, we screened inpatients with terminal cancer admitted between January 2017 and May 2019 to a single hospice-palliative care unit. Clinical characteristics and laboratory results were obtained from medical records for multivariable Cox regression analysis of independent prognostic factors. Results: Of the 487 patients who qualified, 15 (3%) were hypernatremic upon admission. The median survival time was 26 days. Parameters associated with shortened survival included male sex, advanced age (> 70 years), lung cancer, poor performance status, elevated inflammatory markers, azotemia, impaired liver function, and hypernatremia. In a multivariable Cox proportional hazards model, male sex (hazard ratio [HR] = 1.53, 95% confidence interval [CI]: 1.15–2.04), poor performance status (HR = 1.45, 95% CI: 1.09–1.94), leukocytosis (HR = 1.98, 95% CI: 1.47–2.66), hypoalbuminemia (HR = 2.06, 95% CI: 1.49–2.73), and hypernatremia (HR = 1.55, 95% CI: 1.18– 2.03) emerged as significant predictors of poor prognosis. Conclusion: Hypernatremia may be a useful gauge of prognosis in patients with terminal cancer. Further large- scale prospective studies are needed to corroborate this finding.
    [Show full text]
  • Childhood Sustained Hypercalcemia: a Diagnostic Challenge
    ORI GI NAL AR TIC LE DO I: 10.4274/jcrpe.4247 J Clin Res Pediatr Endocrinol 2017;9(4):315-322 Childhood Sustained Hypercalcemia: A Diagnostic Challenge Nisa Eda Çullas İlarslan1, Zeynep Şıklar2, Merih Berberoğlu2 1Ankara University Faculty of Medicine, Department of Pediatrics, Ankara, Turkey 2Ankara University Faculty of Medicine, Department of Pediatric Endocrinology, Ankara, Turkey What is already known on this topic? Hypercalcemia is a rare finding in children which may be due to a wide variety of factors and possibly left undiagnosed in mild elevations, while carrying the potential to lead to serious complications if proper intervention is not achieved. What this study adds? Suspicion of hypercalcemia and measurement of serum calcium level in children with clinical findings not attributable to any other clinical condition is essential. In case of hypercalcemia, young infants are more vulnerable to development of nephrolithiasis and should be evaluated as soon as possible. Abstract Objective: This study aimed to call attention to hypercalcemia, a rare finding in children which carries the potential of leading to serious complications without proper intervention. Methods: Diagnosis, treatment, and clinical course of children with sustained hypercalcemia admitted between the years 2006-2016 were reviewed. Group 1 [parathyroid hormone (PTH)-dependent] consisted of patients with high/unsuppressed PTH levels and group 2 (PTH-independent) included cases with normal/suppressed PTH levels. Results: Twenty patients (11 male, 9 female) with a median age of 6.25 (0.03-17.88) years were evaluated. Symptoms were mostly related with the gastrointestinal system, while six patients (30%) were asymptomatic. Physical examination findings were diverse, non-specific, and normal in four patients (20%).
    [Show full text]
  • Serum Calcium and Magnesium Abnormalities in Patients with Status
    Pakistan Journal of Neurological Sciences (PJNS) Volume 10 | Issue 3 Article 6 12-2015 Serum calcium and magnesium abnormalities in patients with status epilepticus: a single centre tertiary care experience Uzma Jamil Pakistan Institute of Medical Sciences,Islamabad Mazhar Badshah Pakistan Institute of Medical Sciences,Islamabad Ali Zohair Nomani Pakistan Institute of Medical Sciences,Islamabad Muhammad Irshad Pakistan Institute of Medical Sciences,Islamabad Jamal Janjua Pakistan Institute of Medical Sciences,Islamabad Follow this and additional works at: http://ecommons.aku.edu/pjns Part of the Neurology Commons Recommended Citation Jamil, Uzma; Badshah, Mazhar; Nomani, Ali Zohair; Irshad, Muhammad; and Janjua, Jamal (2015) "Serum calcium and magnesium abnormalities in patients with status epilepticus: a single centre tertiary care experience," Pakistan Journal of Neurological Sciences (PJNS): Vol. 10: Iss. 3, Article 6. Available at: http://ecommons.aku.edu/pjns/vol10/iss3/6 INTRODUCTION and burden of PSD is likely to happen because of the decline in mortality after stroke and ageing of Stroke is the major cause of physical disability in adults, populations.1 The 24 year study also indicated that the second most common cause of dementia, and the prevalence of Post stroke Dementia associated with third leading cause of death (after coronary-artery lacunar stroke was 7 times higher than other types of diseases and cancers).2 Vascular cognitive impairment stroke, including Intracerebral hemorrhage6. According is decline caused by ischemic, hemorrhagic, or oligemic to Nys et al., a high proportion of stroke survivors injury to the brain as a consequence of cerebrovascular developed the cognitive impairment within 3 months of disease.It is one of the main causes of dependency in stroke.
    [Show full text]
  • The Co-Existence of Vulvar Lichen Sclerosus, Ulcerated Calcinosis Cutis, and Dermatomyositis: Coincidence Or Immunological Mechanism?
    Lichen Sclerosus, Calcinosis Cutis and Dermatomyositis Ann Dermatol Vol. 23, Suppl. 3, 2011 http://dx.doi.org/10.5021/ad.2011.23.S3.S375 CASE REPORT The Co-Existence of Vulvar Lichen Sclerosus, Ulcerated Calcinosis Cutis, and Dermatomyositis: Coincidence or Immunological Mechanism? Didem Didar Balcı, M.D., Ebru Çelik, M.D., Gökhan Sarıkaya, M.D., Jülide Zehra Yenin, M.D., Esin Atik, M.D.1 Departments of Dermatology, 1Pathology, Faculty of Medicine, Mustafa Kemal University, Antakya-Hatay, Turkey Calcinosis cutis is a condition characterized by the de- proximal extensor myopathy. Calcinosis cutis is frequently position of calcium salts in the skin and subcutaneous accompanied by juvenile dermatomyositis (JDM). Ulcera- tissues, and patients suffering from it encounter various tion may be observed in the lesions of calcinosis cutis1,2. connective tissue disorders, such as dermatomyositis (DM), Cases of the co-existence of ulcerated calcinosis cutis and scleroderma, and systemic lupus erythematosus. Although adult DM have been rarely reported3,4. The current case is calcinosis cutis is frequently accompanied by juvenile presented due to the relatively rare incidence of ulcerated dermatomyositis, rare cases have been reported in adult calcinosis cutis in patients with adult DM, as well as the patients with DM. On the other hand, lichen sclerosus (LS) is co-existence of vulvar lichen sclerosus (LS), which has not a chronic inflammatory disease of the skin and mucosal been reported previously to the best of our knowledge. surfaces. In the present report, we present a rare case of a 71-year-old patient with DM accompanied by ulcerated CASE REPORT calcinosis cutis and vulvar LS.
    [Show full text]
  • Prevalence of Patient Load with Electrolyte Abnormalities Presenting to Emergency Department at a Tertiary Care Hospital
    International Journal of Health Sciences and Research Vol.10; Issue: 6; June 2020 Website: www.ijhsr.org Original Research Article ISSN: 2249-9571 Prevalence of Patient Load with Electrolyte Abnormalities Presenting To Emergency Department at a Tertiary Care Hospital Abdul Wahid Bhat1, Basil Wahid Bhat2 1Additional Professor Emergency Medicine, 2Medical Student, Sher-I-Kashmir Institute of Medical Sciences, Soura Srinagar, Kashmir Corresponding Author: Abdul Wahid Bhat ABSTRACT Disturbances in electrolytes are frequently observed in the emergency departments. There were 12500 patients admission (episodes) with various electrolyte abnormalities studied to check the prevalence of electrolyte imbalance in the patients admitted in the emergency department of a tertiary care hospital. Hyper and hypo abnormalities in Potassium, sodium and calcium were the common abnormalities and were present in 40.7%, 36.16% and 6.7% respectively. Patients with malignancy pre dominantly had electrolyte imbalances particularly hyponatremia, hypokalemia and hypercalcemia. Because of the high incidence rate of chronic co morbid conditions with electrolyte imbalance have multiple admission to ED, The ED physicians must be acknowledged and understand the dynamics of fluid and electrolyte balance and their early correction in patients admitted for short term care in the emergency department. The routine measurement of these electrolytes in all patients admitted in emergency department may be warranted for early detection and correction of any derangement in various electrolytes. Key words: Episodes, Electrolyte imbalance, hyponatremia, hyponatremia, hyperkalemia, hypokalemia, hypocalcaemia, hypercalcemia INTRODUCTION sulphate and phosphate being the major Disturbances in electrolytes are anions. Electrolyte imbalances are frequently observed in the emergency commonly observed in many medical and department (ED) and have important surgical conditions.
    [Show full text]
  • Electrolyte Imbalance
    Electrolyte Imbalance An electrolyte is a substance in the bloodstream that regulates important body functions. Some electrolytes are potassium, magnesium, sodium, phosphorous and calcium. Electrolytes are necessary so that muscles, organs (like the heart) and organ systems (like the nervous system) work properly. Electrolyte levels can be measured when blood is drawn for testing. If the levels are too high or too low, this is called an electrolyte imbalance. Causes of Electrolyte Imbalance There are many causes of an electrolyte imbalance, including: Loss of body fluids from vomiting, diarrhea, sweating or high fever. Chemotherapy. Medications, such as furosemide (Lasix®), that help patients with water retention. Antibiotics, such as AmBisome® and Cancidas®. Immunosuppressants, such as cyclosporine. Poor diet or not getting enough vitamins from food. Symptoms Common symptoms of electrolyte imbalance include irregular heartbeat, confusion, fatigue, lightheadedness, blood pressure changes, muscle weakness or twitching, numbness and seizures. In general, a person with an electrolyte imbalance does not feel very well or want to be involved in much activity. Electrolyte Imbalances in Patients Common electrolyte imbalances in patients include low potassium and low magnesium. The easiest way to replace the body’s supply is to eat foods that are rich in potassium and magnesium. Some examples of potassium-rich foods are: Dried fruits such as raisins, prunes, apricots and dates. Fruits such as bananas, strawberries, watermelon, oranges and cantaloupe. Dried vegetables such as beans and peas. Fresh meats like turkey, fish and beef. Baked potato (with skin). Some examples of magnesium-rich foods are: Peanuts and peanut butter. Broccoli, spinach, okra, squash, corn and brown rice.
    [Show full text]
  • “Hyponatremia in Stroke: Cerebral Salt Wasting Versus Syndrome of Inappropriate Anti-Diuresis”
    IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861.Volume 15, Issue 7 Ver. II (July. 2016), PP 00-00 www.iosrjournals.org “Hyponatremia in Stroke: Cerebral Salt Wasting Versus Syndrome of Inappropriate Anti-Diuresis” Dr. Kumar Natarajan, Md,Ficp1, Dr. Mithra Prasad2 1(Professor And HOD, Department Of Medicine , Coimbatore Medical College/ Tamil Nadu Dr.MGR University, India) 2 (Post Graduate, Department Of Medicine , Coimbatore Medical College/ Tamil Nadu Dr.MGR University, India) Abstract: Hyponatremia is the most common electrolyte imbalance in neurologic patients. The causes of hyponatremia are varied, but in neurologically ill patients, is most commonly attributed to Syndrome of Inappropriate Anti-diuresis and Cerebral Salt Wasting. Both these entities are cerebral in origin but have distinct pathophysiology, prognosis and treatment options. The importance of distinguishing both lies in the fact that the therapy indicated for one if used for the other, can be deleterious. SIADH is a subclinically volume expanded state due to inappropriate anti-diuresis.. In stroke SIADH occurs due to AVP secretion inappropriate to the osmotic threshold. It thus requires fluid restriction as the treatment. CSW, on the other hand, is essentially a volume depleted state, which occurs due to the combined effects of decreased sympathetic outflow and increased natriuretic peptides and needs rigorous volume repletion. Hyponatremia, especially Cerebral Salt Wasting, occurring in the setting of stroke has been shown to worsen the prognosis of stroke, increase morbidity, short and long term mortality, and cause a poorer discharge disposition.. The purpose of this study is to observe the occurrence of SIADH vs CSW in the setting of stroke and to study the short term mortality, morbidity and discharge disposition among the two entities.
    [Show full text]
  • Electrolyte Imbalance
    Electrolyte Imbalance For Providers Myth: Volume depletion and electrolyte imbalance are interchangeable terms. Fact: While we often use these terms interchangeably, they are actually different conditions and require different treatment. Volume depletion is the loss of salt and water. Residents with volume depletion may show changes to the BUN and creatinine or present with new orthostatic hypotension. Treatment of volume depletion requires replacement of both sodium and water, usually with normal saline. Electrolyte imbalance is loss of water only. In true dehydration, the sodium is always elevated. Treatment of residents with electrolyte imbalance requires replacement of water deficit with oral water (mild electrolyte imbalance) or with intravenous fluids. Giving a patient with true electrolyte imbalance (hypernatremia) normal saline is likely to worsen their condition. Myth: Electrolyte imbalance can be diagnosed by physical exam. Fact: While there are some signs on physical exam that may lead you to think about electrolyte imbalance such as dry tongue or dry axilla, these are nonspecific. The diagnosis of electrolyte imbalance is a laboratory diagnosis. You need to get at least a BMP. Dehydration is diagnosed by hypernatremia (deficit of free water). Volume depletion is diagnosed by changes to the BUN and creatinine. Myth: If a patient has a G-tube, then I don’t need to place an IV to hydrate them. Fact: For residents with mild to moderate electrolyte imbalance, you may be able to hydrate them through their g-tube. However, for severe electrolyte imbalance or volume depletion, you likely still need to place an IV as the ability of the gut to absorb fluids will limit your ability to replenish fluids quickly enough for these residents.
    [Show full text]
  • University of Illinois, December 2003
    Case #1 Case Presented by Virginia C. Fiedler, MD, Michelle Bain, MD and Alexander L. Berlin, MD History of Present Illness: This 9-year-old African American girl presented with hair shedding and patchy hair loss since infancy. Additionally, her hair has been brittle. Her scalp is comfortable, without pruritus. The patient’s mother has also noticed deviations of multiple finger joints since the age of 3 along with more recent similar changes in toe joints. These changes are not associated with pain or joint swelling. The patient denies decreased body sweating, but she does note increased sweating in the areas of scalp hair loss. Past Medical History: Febrile seizures as a child Multiple finger and toe joint deviations starting at 3 years of age History of ankle deformities treated with braces for 2 years Medications: None Allergies: No known drug allergies Family History: No history of autoimmune or other skin disorders; no joint abnormalities Social History: Patient is a 4th grade student and is doing well in school Review of Systems: Denies visual problems or arthralgias Diet is adequate for protein Physical Examination: The patient had patchy alopecia that was most pronounced in the ophiasis distribution and also involved the vertex. The affected areas had miniaturized hair follicles. Hair pull test was positive for 5-6 hairs in catagen and telogen phases. Ears were not low-set. There was an increased distance between the nose and the upper lip, and the philtrum was difficult to appreciate. The patient had retained deciduous teeth, as well as hypodontia and partial anodontia.
    [Show full text]